Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy

Author： Brumlik Michael J   Daniel Benjamin J   Waehler Reinhard   Curiel David T   Giles Francis J   Curiel Tyler J  

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.5, Iss.1, 2008-01, pp. : 87-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ligand-based targeted therapy for cancer tissue

By Das Manasi   Mohanty Chandana   Sahoo Sanjeeb K  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 3, 2009-03 ,pp. : 285-304

Informa Healthcare

Access to resources Recommend Favorite

Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

By Gindy Marian E   Prud'homme Robert K  

Expert Opinion on Drug Delivery, Vol. 6, Iss. 8, 2009-08 ,pp. : 865-878

Informa Healthcare

Access to resources Recommend Favorite

Opportunities and challenges of carbon-based nanomaterials for cancer therapy

By Bianco Alberto   Kostarelos Kostas   Prato Maurizio  

Expert Opinion on Drug Delivery, Vol. 5, Iss. 3, 2008-03 ,pp. : 331-342

Informa Healthcare

Access to resources Recommend Favorite

A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle

By Franzen Stefan  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 3, 2011-03 ,pp. : 281-298

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Therapy for Breast Cancer An NIH Consensus Development Conference

By  

Preventive Medicine, Vol. 31, Iss. 1, 2000-07 ,pp. : 90-90

Academic Press

Access to resources Recommend Favorite